Physicians' Academy for Cardiovascular Education

Patient and Physician Perspectives on Administration of the PCSK9 Monoclonal Antibody Alirocumab, an Injectable Medication to Lower LDL-C Levels

Slides (presentation) - June 19, 2015

Presentation prepared and held by dr. Bertrand Cariou (Université de Nantes, France) in Clinical Breakthroughs session: Modifying LDL cholesterol to prevent CV events, Tuesday, May 26, 2015 during ISA2015 (Amsterdam, The Netherlands).

To view slides, click on images

Patient and Physician Perspectives on Administration of the.pdf (0,5MB)Patient and Physician Perspectives.pdf (0,5MB)


The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.